IP Library › Granted Patent US 12,415,879
Granted Patent B2
US 12,415,879 · App. 17/618,353 · Granted Sep 16, 2025

Grafted polymer carrying pendent imidazole functional groups

Inventor: Francois Jean-Baptiste Dit Dominique (Clermont-Ferrand, FR)
Assignee: COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
C08F279/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,415,879
App. No.
17/618,353
Granted
Sep 16, 2025
Kind
B2
Abstract

A modified polymer is obtained by grafting of at least one compound of formula (I) onto at least one unsaturation of the initial polymer chain in which Q represents a dipole comprising at least one nitrogen atom; A represents a divalent heteroaromatic ring optionally substituted with one or more identical or different linear or branched aliphatic hydrocarbon-based chains, optionally substituted or interrupted with one or more heteroatoms; E represents a divalent hydrocarbon-based group which may optionally contain one or more heteroatoms; R 1 represents a hydrogen atom or a C 1 -C 20 alkyl group; and Y and Z, which may be identical or different, each represent a hydrogen atom or a hydrocarbon-based chain, Y and Z together also possibly forming a ring, notably an aromatic ring, with the carbon atoms of the imidazole ring to which they are attached.

Claims (39)

1. A modified polymer obtained by grafting of at least one compound of formula (I) onto at least one unsaturation of an initial polymer chain

in which:

Q represents a dipole comprising at least one nitrogen atom;

A represents a divalent heteroaromatic ring optionally substituted with one or more identical or different linear or branched aliphatic hydrocarbon-based chains, optionally substituted or interrupted with one or more heteroatoms;

E represents a divalent hydrocarbon-based group which may optionally contain one or more heteroatoms;

R 1 represents a hydrogen atom or a C 1 -C 20 alkyl group; and

Y and Z, which may be identical or different, each represent a hydrogen atom or a hydrocarbon-based chain, or Y and Z together form a ring with the carbon atoms of the imidazole ring to which they are attached.

2. The modified polymer according to claim 1 , wherein a molar degree of grafting of the compound of formula (I) is in a range extending from 0.01% to 15%.

3. The modified polymer according to claim 1 , wherein Q is a group of formula (II), (III) or (IV)

in which:

the symbol * represents the attachment of Q to A;

R 2 and R 4 are selected, independently of each other, from a hydrogen atom, a linear or branched C 1 -C 20 alkyl, a C 3 -C 20 cycloalkyl optionally substituted with one or more aliphatic hydrocarbon-based chains, which are optionally saturated, linear or branched, and a C 6 -C 20 aryl optionally substituted with one or more aliphatic hydrocarbon-based chains; and

R 3 is selected from the group consisting of linear or branched C 1 -C 20 alkyls, C 3 -C 20 cycloalkyls optionally substituted with one or more aliphatic hydrocarbon-based chains, and C 6 -C 20 aryls optionally substituted with one or more aliphatic hydrocarbon-based chains.

4. The modified polymer according to claim 3 , wherein the compound of formula (I) is chosen from the compounds of formula (IIa)

in which:

A represents a divalent heteroaromatic ring optionally substituted with one or more identical or different linear or branched aliphatic hydrocarbon-based chains, optionally substituted or interrupted with one or more heteroatoms;

E represents a divalent hydrocarbon-based group which may optionally contain one or more heteroatoms;

R 1 represents a hydrogen atom or a C 1 -C 20 alkyl group;

Y and Z, which may be identical or different, each represent a hydrogen atom or a hydrocarbon-based chain, or Y and Z together form a ring with the carbon atoms of the imidazole ring to which they are attached;

R 2 is selected from a hydrogen atom, a linear or branched C 1 -C 20 alkyl, a C 3 -C 20 cycloalkyl optionally substituted with one or more aliphatic hydrocarbon-based chains, and a C 6 -C 20 aryl optionally substituted with one or more aliphatic hydrocarbon-based chains; and

R 3 is selected from the group consisting of linear or branched C 1 -C 20 alkyls, C 3 -C 20 cycloalkyls optionally substituted with one or more aliphatic hydrocarbon-based chains, and C 6 -C 20 aryls optionally substituted with one or more aliphatic hydrocarbon-based chains.

5. The modified polymer according to claim 1 , wherein A is a divalent heteroaromatic ring formed from 5 to 10 atoms, optionally substituted with one or more identical or different linear or branched, aliphatic C 1 -C 24 hydrocarbon-based chains, optionally substituted or interrupted with one or more heteroatoms.

6. The modified polymer according to claim 4 , wherein the compound of formula (IIa) is selected from compounds of formula (IIb)

in which:

X represents a heteroatom selected from a sulfur atom, an oxygen atom and a nitrogen atom;

E represents a divalent hydrocarbon-based group which may optionally contain one or more heteroatoms;

R 1 represents a hydrogen atom or a C 1 -C 20 alkyl group;

Y and Z, which may be identical or different, each represent a hydrogen atom or a hydrocarbon-based chain, or Y and Z together form a ring with the carbon atoms of the imidazole ring to which they are attached;

R 2 is selected from a hydrogen atom, a linear or branched C 1 -C 20 alkyl, a C 3 -C 20 cycloalkyl optionally substituted with one or more aliphatic hydrocarbon-based chains, and a C 6 -C 20 aryl optionally substituted with one or more aliphatic hydrocarbon-based chains; and

R 3 is selected from the group consisting of linear or branched C 1 -C 20 alkyls, C 3 -C 20 cycloalkyls optionally substituted with one or more aliphatic hydrocarbon-based chains, and C 6 -C 20 aryls optionally substituted with one or more aliphatic hydrocarbon-based chains.

7. The modified polymer according to claim 3 , wherein R 2 is a hydrogen atom and R 3 is selected from C 1 -C 20 alkyls and C 6 -C 20 aryls.

8. The modified polymer according to claim 1 , wherein E is selected from linear or branched, saturated aliphatic C 1 -C 24 , optionally interrupted with one or more nitrogen, sulfur or oxygen atoms.

9. The modified polymer according to claim 1 , wherein E is selected from the groups —R—, —NHR—, —OR— and —SR—, where R is a linear or branched C 1 -C 24 alkylene.

10. The modified polymer according to claim 1 , wherein Y and Z, which may be identical or different, each represent a hydrogen atom or a linear or branched C 1 -C 24 alkyl, or Y and Z together form a ring with the carbon atoms of the imidazole ring to which they are attached.

11. The modified polymer according to claim 1 , wherein Y and Z are a hydrogen atom.

12. The modified polymer according to claim 1 , wherein R 1 is a hydrogen atom or a C 1 -C 6 alkyl.

13. The modified polymer according to claim 1 , wherein the compound of formula (I) is the compound of formula (VIII)

14. The modified polymer according to claim 1 , wherein the initial polymer is an elastomer.

15. A composition comprising at least one modified polymer according to claim 1 and at least one additive.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2022
From: DIT DOMINIQUE, FRANCOIS JEAN-BAPTISTE
To: COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
Reel/Frame 058756/0212 →
Priority Claims (1)
FR 1906182 · Jun 11, 2019 · national
Continuity (1)
Related Publication 20220235164A1 · Jul 28, 2022
References Cited (25)
US 7199175B2 · Vasseur · 2007 [cited by applicant]
US 7900667B2 · Vasseur · 2011 [cited by applicant]
US 9394380B2 · Araujo Da Silva et al. · 2016 [cited by applicant]
US 10030116B2 · Salit et al. · 2018 [cited by applicant]
US 10137734B2 · Gander et al. · 2018 [cited by applicant]
US 10202471B2 · Ugolnikov et al. · 2019 [cited by applicant]
US 20030212185A1 · Vasseur · 2003 [cited by applicant]
US 20070112120A1 · Vasseur · 2007 [cited by applicant]
US 20100016349A1 · Becker et al. · 2010 [cited by applicant]
US 20130131279A1 · Araujo Da Silva et al. · 2013 [cited by applicant]
US 20160251456A1 · Ugolnikov et al. · 2016 [cited by applicant]
US 20160264753A1 · Salit et al. · 2016 [cited by applicant]
US 20190119412A1 · Ugolnikov et al. · 2019 [cited by applicant]
US 20220098400A1 · Jean-Baptiste-Dit-Dominique et al. · 2022 [cited by applicant]
US 20230044213A1 · Jean-Baptiste-Dit-Dominique et al. · 2023 [cited by applicant]
JP 201544929A · 2015 [cited by applicant]
JP 2016535744A · 2016 [cited by applicant]
JP 2016535807A · 2016 [cited by applicant]
JP 2017501240A · 2017 [cited by applicant]
WO 0210269A2 · 2002 [cited by applicant]
WO 2012007441A1 · 2012 [cited by applicant]
WO WO2015059269A1 · 2015 [cited by examiner]
WO WO2015059271A1 · 2015 [cited by examiner]
WO 2020249623A1 · 2020 [cited by applicant]
International Search Report dated Aug. 26, 2020, in corresponding PCT/EP2020/066121 (4 pages). [cited by applicant]